Dyne Therapeutics Archives

Dyne Therapeutics ($DYN) Advances with FDA Breakthrough Therapy Designation for DYNE-101

Staff Writer - June 17, 2025 7:17 am

Dyne Therapeutics, Inc. (DYN) announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to DYNE-101 for the treatment of myotonic...

The information provided is intended solely for informational purposes and should not be regarded as investment guidance. It is advisable to use this information as a foundation for conducting your own independent research to formulate your own investment and trading strategies. Stock price information is derived from independent third-party sources and is presented as received. We do not guarantee the accuracy, completeness, or timeliness of the information provided.

Tag: Dyne Therapeutics

Dyne Therapeutics ($DYN) Advances with FDA Breakthrough Therapy Designation for DYNE-101

EVEN MORE NEWS

Incyte (INCY) Gains FDA Nod for Monjuvi in Relapsed or Refractory...

Ormat Technologies ($ORA) Secures Full Ownership of 20MW Blue Mountain Facility

Guild Holdings Company ($GHLD) shareholders to receive $20 per share, a...

POPULAR CATEGORY